Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Stefanini

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 11, 2025
Occupational toxicants in MASLD: Bias, complexity, and future directionsBernardo Stefanini, Francesco Tovoli
Med (New York, N.Y.)|August 9, 2025
Nivolumab plus ipilimumab: A promising first-line therapy for hepatocellular carcinomaBernardo Stefanini, Fabio Piscaglia
Expert Review of Gastroenterology & Hepatology|March 24, 2025
Thinking outside the box: unconventional artificial intelligence algorithms in the detection and management of liver cirrhosisAhmed Hashim, Bernardo Stefanini, Fabio Piscaglia
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 2, 2021
Ultrasound, the handyman serving our whole populations in the post COVID-19 pandemicFabio Piscaglia, Bernardo Stefanini, Vito Cantisani
Expert Review of Anticancer Therapy|July 22, 2022
Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?Bernardo Stefanini, Matteo Tonnini, Mariarosaria Marseglia, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 6, 2024
Artificial intelligence in Ultrasound: Pearls and pitfalls in 2024Bernardo Stefanini, Alice Giamperoli, Eleonora Terzi, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 8, 2023
Ultrasound in clinical enviroments: Where are we standing?Fabio Piscaglia, Bernardo Stefanini, Fabrizio Calliada, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 10, 2026
Is the hyper-defense of current patients in clinical research reducing the expectations for the cure of future patients? The case of investigator-initiated imaging and treatment studies becoming no longer sustainableFabio Piscaglia, Viola Tarterini, Francesca Girolami, et al.
Expert Opinion on Investigational Drugs|May 10, 2021
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical developmentStefania De Lorenzo, Ingrid Garajova, Bernardo Stefanini, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 15, 2022
Letter to the Editor Regarding the Article "Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement" by Zhou and CollaboratorsBernardo Stefanini, Eleonora Terzi, Alice Giamperoli, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 11, 2025
Occupational toxicants in MASLD: Bias, complexity, and future directionsBernardo Stefanini, Francesco Tovoli
Med (New York, N.Y.)|August 9, 2025
Nivolumab plus ipilimumab: A promising first-line therapy for hepatocellular carcinomaBernardo Stefanini, Fabio Piscaglia
Expert Review of Gastroenterology & Hepatology|March 24, 2025
Thinking outside the box: unconventional artificial intelligence algorithms in the detection and management of liver cirrhosisAhmed Hashim, Bernardo Stefanini, Fabio Piscaglia
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 2, 2021
Ultrasound, the handyman serving our whole populations in the post COVID-19 pandemicFabio Piscaglia, Bernardo Stefanini, Vito Cantisani
Expert Review of Anticancer Therapy|July 22, 2022
Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?Bernardo Stefanini, Matteo Tonnini, Mariarosaria Marseglia, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 6, 2024
Artificial intelligence in Ultrasound: Pearls and pitfalls in 2024Bernardo Stefanini, Alice Giamperoli, Eleonora Terzi, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 8, 2023
Ultrasound in clinical enviroments: Where are we standing?Fabio Piscaglia, Bernardo Stefanini, Fabrizio Calliada, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 10, 2026
Is the hyper-defense of current patients in clinical research reducing the expectations for the cure of future patients? The case of investigator-initiated imaging and treatment studies becoming no longer sustainableFabio Piscaglia, Viola Tarterini, Francesca Girolami, et al.
Expert Opinion on Investigational Drugs|May 10, 2021
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical developmentStefania De Lorenzo, Ingrid Garajova, Bernardo Stefanini, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 15, 2022
Letter to the Editor Regarding the Article "Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement" by Zhou and CollaboratorsBernardo Stefanini, Eleonora Terzi, Alice Giamperoli, et al.
Pageof 7